Canada
Regulations Amending the Patented Medicines (Notice of Compliance) Regulations
| Year of current version: | 2008 |
|---|---|
| Date of Text (Issued): | June 12, 2008 |
| Type of Text: | Implementing Rules/Regulations |
| Subject Matter: | Enforcement of IP and Related Laws, Industrial Property, IP Regulatory Body, Patents (Inventions) |
| Notes: | |
| Available Texts: | |
| English | Regulations Amending the Patented Medicines (Notice of Compliance) Regulations |
| French | Règlement modifiant le Règlement sur les médicaments brevetés (Avis de conformité) |
| Related Legislation: | |
| WIPO Lex No.: | CA056 |
![Regulations Amending the Patented Medicines (Notice of Compliance) Regulations, Complete document (pdf) [39 KB]](/shared/images/icon/new/pdf.gif){kind=icon}
Shortcuts
The notification by Canada to the WTO under Article 63.2 of TRIPS states:
'These Regulations reinforce the predictability, stability and competitiveness of Canada’s intellectual property (IP) regime for pharmaceuticals by reaffirming and clarifying the intended effect of a transitional measure included in an earlier round of amendments to the same instrument. The intention of that measure was to ensure that patents eligible for protection under the Regulations as they were prior to October 5, 2006 remain so until expiry.'